Northern Trust Corp Makes New Investment in SAB Biotherapeutics, Inc. (NASDAQ:SABS)
Northern Trust Corp purchased a new stake in shares of SAB Biotherapeutics, Inc. (NASDAQ:SABS – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 11,387 shares of the company’s stock, valued at approximately $43,000. Separately, Geode Capital Management LLC boosted its position in […]
